Ferriere J M, Parienté J L, Mettetal P J, Allard P, Chabannes E, Maire J, Mevel O, Le Guillou M
Unité d'Urologie et de Chirurgie de la Transplantation, CHU Pellegrin-Tripode, Bordeaux.
Prog Urol. 1994 Aug-Sep;4(4):563-8.
The occurrence of upper urinary tract tumors has been studied in 479 patients followed for bladder cancer: The incidence rate is low (2.9%) but increases with time (mean: 58 months). Some patients are more exposed: those who underwent repeated transurethral resections of Ta-T1 multifocal bladder carcinoma. Retrograde and voiding cystourethrogram seems to be useful to select a group "at risk" during the follow-up of patients with bladder tumors treated by endoscopic resection: a yearly excretory urography for upper urinary tract survey should then be performed.
对479例膀胱癌随访患者的上尿路肿瘤发生情况进行了研究：发病率较低（2.9%），但随时间增加（平均：58个月）。一些患者风险更高：那些接受过Ta-T1多灶性膀胱癌多次经尿道切除术的患者。逆行性和排尿性膀胱尿道造影似乎有助于在内镜切除治疗的膀胱肿瘤患者随访期间选择“高危”人群：随后应每年进行一次排泄性尿路造影以检查上尿路。
